Rosiglitazone for type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rosiglitazone for type 2 diabetes mellitus

Published:2007-07-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Richter Bernd¹,Bandeira-Echtler Elizabeth¹,Bergerhoff Karla¹,Clar Christine²,Ebrahim Susanne H³

Affiliation:

1. Universitaetsklinikum Duesseldorf, Heinrich-Heine University; Department of General Practice; PO Box 101007 Duesseldorf Germany 40001

2. Cochrane Metabolic and Endocrine Disorders Group; Researcher in Systematic Reviews ; Hasenheide 67 Berlin Germany 10967

3. Institute for Quality and Efficiency in Health Care; Dillenburger Str. 27 Cologne Germany 51105

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006063.pub2/fullpdf

Reference146 articles.

1. Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride;Derosa;Hypertension Research,2005

2. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial;Derosa;Clinical Therapeutics,2004

3. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome;Derosa;Diabetes Research & Clinical Practice,2005

4. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome;Derosa;Journal of Clinical Pharmacology and Therapeutics,2006

5. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin;Derosa;Internal Medicine Journal,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxicity and toxicoproteomics analysis of thiazolidinedione exposure in human‐derived cardiomyocytes;Journal of Applied Toxicology;2024-04-23

2. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas;World Journal of Gastroenterology;2023-07-14

3. Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro;Frontiers in Pharmacology;2022-04-28

4. Identification of key candidate genes and molecular pathways in white fat browning: an anti-obesity drug discovery based on computational biology;Human Genomics;2019-11-07

5. Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in Chronic Granulomatous Disease Patients?;Frontiers in Immunology;2019-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3